Evidence map›Paper›PMID 24842522›Full record

ArticlePloS one2014

Identification of the key differential transcriptional responses of human whole blood following TLR2 or TLR4 ligation in-vitro.

Simon Blankley, Christine M Graham, Ashleigh Howes, Chloe I Bloom, Matthew P R Berry, Damien Chaussabel, Virginia Pascual, Jacques Banchereau, Marc Lipman, Anne O'Garra

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Simon BlankleyDivision of Immunoregulation, MRC National Institute for Medical Research, London, United Kingdom.
Christine M GrahamDivision of Immunoregulation, MRC National Institute for Medical Research, London, United Kingdom.
Ashleigh HowesDivision of Immunoregulation, MRC National Institute for Medical Research, London, United Kingdom.
Chloe I BloomDivision of Immunoregulation, MRC National Institute for Medical Research, London, United Kingdom.
Matthew P R BerryDivision of Immunoregulation, MRC National Institute for Medical Research, London, United Kingdom; Department of Respiratory Medicine, Imperial College Healthcare NHS trust, London, United Kingdom.
Damien ChaussabelBaylor Institute for Immunology Research/ANRS Center for Human Vaccines, INSERM, Dallas, Texas, United States of America; Systems Immunology, Benaroya Research Institute, Seattle, Washington, United States of America.
Virginia PascualBaylor Institute for Immunology Research/ANRS Center for Human Vaccines, INSERM, Dallas, Texas, United States of America.
Jacques BanchereauThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, United States of America.
Marc LipmanDepartment of Respiratory Medicine, Royal Free London NHS Foundation Trust, University College London, London, United Kingdom.
Anne O'GarraDivision of Immunoregulation, MRC National Institute for Medical Research, London, United Kingdom; Department of Medicine, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Benaroya Research InstituteImperial College Healthcare NHS Trust · GBImperial College London · GBJackson Laboratory · USUniversity College London · GB

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Medical Research Council MC_U117565642Medical Research Council U117565642NCI NIH HHS P30 CA034196
6 · The paper itself

Abstract

The use of human whole blood for transcriptomic analysis has potential advantages over the use of isolated immune cells for studying the transcriptional response to pathogens and their products. Whole blood stimulation can be carried out in a laboratory without the expertise or equipment to isolate immune cells from blood, with the added advantage of being able to undertake experiments using very small volumes of blood. Toll like receptors (TLRs) are a family of pattern recognition receptors which recognise highly conserved microbial products. Using the TLR2 ligand (Pam3CSK4) and the TLR4 ligand (LPS), human whole blood was stimulated for 0, 1, 3, 6, 12 or 24 hours at which times mRNA was isolated and a comparative microarray was undertaken. A common NFκB transcriptional programme was identified following both TLR2 and TLR4 ligation which peaked at between 3 to 6 hours including upregulation of many of the NFκB family members. In contrast an interferon transcriptional response was observed following TLR4 but not TLR2 ligation as early as 1 hour post stimulation and peaking at 6 hours. These results recapitulate the findings observed in previously published studies using isolated murine and human myeloid cells indicating that in vitro stimulated human whole blood can be used to interrogate the early transcriptional kinetic response of innate cells to TLR ligands. Our study demonstrates that a transcriptomic analysis of mRNA isolated from human whole blood can delineate both the temporal response and the key transcriptional differences following TLR2 and TLR4 ligation.

Indexed as

BloodGene Expression ProfilingGene Expression RegulationHumansIn Vitro TechniquesLipopeptidesLipopolysaccharidesMicroarray AnalysisNF-kappa BTime FactorsToll-Like Receptor 2Toll-Like Receptor 4LipopeptidesLipopolysaccharidesNF-kappa BPam(3)CSK(4) peptideTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID24842522
PMCPMC4026482
OpenAlexW2026918953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.